MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 22, 2022 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Certificate Under Regulation 40(9) / 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From 01St April 2021 To 31St March, 2022
In terms of Regulation 40(9) / 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time please find attached herewith the Certificate for the period from 01st April 2021 to 31st March, 2022 issued by Sandeep Gandhi & Co. - Practicing Company Secretaries. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 18, 2022 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Mangalam Drugs & Organics Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Results of Postal Ballot by remote e-voting process pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Scrutinizers Report MANGALAM DRUGS & ORGANICS LTD. - 532637 - Submission Of Proceedings Of Postal Ballot
Pursuant to Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Summary of Proceeding of the Postal Ballot conducted by the Company through Remote e-voting. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022.
In terms of Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time please find attached herewith the Compliance Certificate under the aforesaid regulation duly signed by the Compliance Officer of the Company and Authorised Representative of Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the year ended March 31, 2022. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- GOVARDHAN M DHOOTDesignation :- Managing Director / Whole Time Director MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time please find attached herewith the Compliance Certificate as received from 'Link Intime India Private Limited' Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2022. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 01, 2022 for Shree Rasbihari Trading and Investment Pvt Ltd